Rocket Doctor AI

Rocket Doctor AI Equity

Delisted

The The Equity of Rocket Doctor AI (TRUE.CN) as of Nov 16, 2026 is 792,800.00 CAD. In the previous year, The Equity was -738,100.00 CAD — a change of -207.41% (higher).

Equity

792,800.00CAD

YoY

-207.41%

Last updated:

In 2024, Rocket Doctor AI's equity was 792,800.00 CAD, a -207.41% increase from the -738,100.00 CAD equity in the previous year.

The Rocket Doctor AI Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2017
-36,800.00 CAD
Jan 1, 2018
10,000.00 CAD
Jan 1, 2019
350,100.00 CAD
Jan 1, 2020
-263,300.00 CAD
Jan 1, 2021
109,900.00 CAD
Jan 1, 2022
-2.19 M CAD
Jan 1, 2023
-738,100.00 CAD
Jan 1, 2024
792,800.00 CAD
The Rocket Doctor AI Equity history
YEAREquityYoY
792,800.00CAD-207.41%
-738,100.00CAD-66.28%
-2.19 MCAD-2,091.45%
109,900.00CAD-141.74%
-263,300.00CAD-175.21%
350,100.00CAD+3,401.00%
10,000.00CAD-127.17%
-36,800.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rocket Doctor AI Stock analysis

What does Rocket Doctor AI do? Treatment.com AI Inc generates revenue through its Treatment Digital Health App, a symptom assessment tool developed by a global team of doctors and engineers. The app provides predictive health insights using disease rate estimates, geographic variation data, and medical research, targeting patients and caregivers seeking informed health decisions. The company also offers medical education solutions and clinical advisor services, serving healthcare professionals and institutions globally. Revenue streams include subscriptions for app access and tailored medical education programs. The Treatment Digital Health App is designed for widespread use, offering advanced medical knowledge access to users worldwide. Medical clinic solutions are integrated into the platform, supporting healthcare providers in decision-making. Clinical advisor services leverage the AI platform to assist clinics and institutions with specialized medical guidance. These offerings are marketed to healthcare consumers, clinics, and educational institutions as part of the company's global healthcare technology strategy. Treatment.com AI Inc's business model focuses on AI-driven health solutions, with the Treatment Digital Health App as its primary product. The app's predictive health assessments are updated regularly by medical professionals, ensuring relevance and accuracy. The company monetizes through direct consumer subscriptions and B2B partnerships with medical clinics and educational providers, emphasizing global accessibility and evidence-based medical insights. Rocket Doctor AI is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Rocket Doctor AI's Equity

Rocket Doctor AI's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Rocket Doctor AI's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Rocket Doctor AI's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Rocket Doctor AI's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Rocket Doctor AI’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Rocket Doctor AI stock

The Equity of Rocket Doctor AI is 792,800.00 CAD in 2024.

The Equity of Rocket Doctor AI changed from -738,100.00 CAD to 792,800.00 CAD, representing a -207.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Rocket Doctor AI since 2006 – with annual values, charts, and detailed analysis.

The Equity's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Rocket Doctor AI historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Rocket Doctor AI

All Key Metrics — Rocket Doctor AI